Professor, Medicine, University of Colorado School of Medicine
Nephrology
Dr. Patricia A. Gabow, MD
|
|
Give Review
Dr. Patricia A. Gabow works in the field of Nephrology. She graduated from Perelman School of Medicine at the University of Pennsylvania. She received awards:"Whos Who in Medicine and Healthcare". Dr. Patricia A. Gabow is also published. She has 99 publications published. The lastest publication: "Unrecognized adult salicylate intoxication.'
Publications
- Marshaling leadership for high-value health care: an Institute of Medicine discussion paper.
- A broad and structured approach to improving patient safety and quality: lessons from denver health.
- Denver Health. Transforming care across the continuum.
- Changes in insurance status and access to care in an integrated safety net healthcare system.
- Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history.
- Inspired leadership: Dr. Patricia Gabow talks about pursuing transformation and why mentoring matters.
- Can America's urban safety net systems be a solution to unequal treatment?
- Observations of residents' work activities for 24 consecutive hours: implications for workflow redesign.
- Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO.
- Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up.
- Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease.
- Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
- An 'open door' for the vulnerable. Even after reform is in place, need for safety net providers will be great.
- The effect of automated alerts on provider ordering behavior in an outpatient setting.
- Using computerized clinical decision support for latent tuberculosis infection screening.
- Evaluating patient compliance with nurse advice line recommendations and the impact on healthcare costs.
- Follow the evidence. Administrative rules, regulations should get comparative-effectiveness treatment.
- Denver Health: a model for the integration of a public hospital and community health centers.
- Segregation analysis of autosomal dominant polycystic kidney disease.
- Improvements in billing processes and information systems increase cash collections in a public health care system.
- Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease.
- Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.
- Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease.
- Adrenal insufficiency after unilateral radical nephrectomy.
- Arteriovenous fistula from drug abuse. Implications for hemodialysis.
- Frequently nebulized beta-agonists for asthma: effects on serum electrolytes.
- Autosomal dominant polycystic kidney disease in childhood: a longitudinal study.
- Clinical effect of morning report.
- Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts.
- Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin.
- The spectrum of autosomal dominant polycystic kidney disease in children.
- Is there evidence for anticipation in autosomal-dominant polycystic kidney disease?
- Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.
- Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease.
- Hereditary and acquired cystic disease of the kidney.
- Causes of death in autosomal dominant polycystic kidney disease.
- Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease.
- Improving identification of and intervention for alcoholism.
- Fanconi's syndrome and distal renal tubular acidosis after glue sniffing.
- Syndromes of toluene sniffing in adults.
- The spectrum of rhabdomyolysis.
- Diagnostic importance of an increased serum anion gap.
- Polycystic kidney disease: prospective analysis of nonazotemic patients and family members.
- Urinary chloride concentration in acute renal failure.
- The role of alcohol in new-onset atrial fibrillation.
- Nephrotoxicity following single dose mithramycin therapy.
- Comparison of hospitalization between nursing home and community residents.
- Prevention of hypercalcemia-induced renal concentrating defect and tissue calcium accumulation.
- Organic acids in ethylene glycol intoxication.
- Echocardiographic findings in autosomal dominant polycystic kidney disease.
- Ethylene glycol intoxication.
- Hypertension in autosomal dominant polycystic kidney disease.
- Linkage heterogeneity of autosomal dominant polycystic kidney disease.
- The clinical utility of renal concentrating capacity in polycystic kidney disease.
- Disorders associated with an altered anion gap.
- Pathophysiology of adult polycystic kidney disease.
- A new method for studying human polycystic kidney disease epithelia in culture.
- Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease.
- Severe acid-base abnormalities associated with cocaine abuse.
- Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates.
- Psychogenic adipsia in a patient with psychotic depression.
- Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease.
- Intra- and extracellular proteins in human normal and polycystic kidney epithelial cells.
- Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease.
- The fall of the serum anion gap.
- Autosomal dominant polycystic kidney disease--more than a renal disease.
- The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
- Renal structure and hypertension in autosomal dominant polycystic kidney disease.
- Toluene abuse during pregnancy: obstetric complications and perinatal outcomes.
- Marked elevations of serum alkaline phosphatase in patients with AIDS.
- Exclusion of autosomal dominant polycystic kidney disease type II (ADPKD2) from 160 cM of chromosome 1.
- Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease.
- Renal manifestations: complication management and long-term outcome of autosomal dominant polycystic kidney disease.
- Polycystic kidney disease: clues to pathogenesis.
- Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.
- Genetic linkage studies of autosomal dominant polycystic kidney disease: search for the second gene in a large Sicilian family.
- Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.
- Intracranial aneurysms in autosomal dominant polycystic kidney disease.
- Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease.
- Autosomal dominant polycystic kidney disease.
- Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23.
- Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen.
- Natural history of autosomal dominant polycystic kidney disease.
- Concepts and controversies in salicylate toxicity.
- Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant.
- Unrecognized adult salicylate intoxication.
- Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case.
- Furosemide-induced reduction in ionized calcium in hypoparathyroid patients.
- Renal cell carcinoma: unusual systemic manifestations.
- Acid-base disturbances in the salicylate-intoxicated adult.
- Urinary diagnostic indices in acute renal failure: a prospective study.
- Spironolactone-induced hyperchloremic acidosis in cirrhosis.
- Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.
- Renal asymmetry in children with autosomal dominant polycystic kidney disease.
- Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease.
- From the bedside to the boardroom.
- Futile care: prevention and process: educating patients about advance directives is crucial.
- Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.
Schools
University Of Pennsylvania School Of Medicine
Hospital Of The University Of Pennsylvania
Harbor Genl Hospital
San Francisco General Hospital
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
University of Pennsylvania Health System -
UCSF -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Denver Health
Helpful Reviews
Similar Doctors
|
Dr. Sameer Bisarya, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Krishna K. Ratnam, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Melvyn H. Klein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David M. Spiegel, MD |
|
|
Dr. Anna J. Jovanovich, MD |
|
Dr. Michael D. Shapiro, MD |
|
Dr. Stuart I. Senkfor, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark A. Dillingham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa J. Yanover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine L. Kelleher, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Geoffrey A. Block, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory S. Schlessinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muhammad Z. Qureshi, MD
This Doctor is OpenDoctor Recommended.
|